| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს გრასსე ფარმა ჯორჯია |
|---|---|---|
| Growth | ||
| Revenue | ₾13.7m₾6.0m | ₾1.4m₾5.7m |
| Revenue growth | 127.9% | -75.5% |
| Profitability | ||
| EBITDA | ₾2.7m-₾474k | ₾36k₾291k |
| EBITDA margin | 20.0%-7.9% | 2.6%5.1% |
| Net profit | ₾2.6m-₾496k | -₾1.2m₾291k |
| Net margin | 19.2%-8.3% | -86.4%5.1% |
| Balance sheet | ||
| Total assets | ₾3.8m₾894k | ₾16.3m₾19.0m |
| Total equity | ₾1.6m-₾493k | ₾16.0m₾17.2m |
| ROE | 167.4% | -7.5%1.7% |